Top Markets
Coin of the day
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited

SUNPHARMA
Classement en actions #478
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company,... Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances; generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.
Prix de l'action
$19.63
Capitalisation boursière
$47.10B
Changement (1 jour)
1.80%
Changement (1 an)
-7.33%
Pays
IN
Échange Sun Pharmaceutical Industries Limited (SUNPHARMA)

Catégorie

Bénéfices pour Sun Pharmaceutical Industries Limited (SUNPHARMA)
Bénéfices en Dec 2025 TTM : $1.64B
Selon les derniers rapports financiers de Sun Pharmaceutical Industries Limited, les bénéfices actuels de l'entreprise sont de $1.64B. En 2024, l'entreprise a réalisé un bénéfice de $1.33B, une augmentation par rapport à celui de 2023 qui était de $1.14B. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Sun Pharmaceutical Industries Limited de 2004 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
2026 (TTM) $1.64B 2.22%
2025 $1.61B 21.21%
2024 $1.33B 16.34%
2023 $1.14B 93.65%
2022 $588.17M 54.49%
2021 $380.72M -42.58%
2020 $663.01M 20.88%
2019 $548.49M 3.41%
2018 $530.42M -62.03%
2017 $1.40B 40.80%
2016 $992.01M -3.13%
2015 $1.02B 33.99%
2014 $764.30M -3.90%
2013 $795.33M 20.15%
2012 $661.93M 44.90%
2011 $456.82M 45.01%
2010 $315.02M -17.95%
2009 $383.94M -3.94%
2008 $399.69M 107.87%
2007 $192.27M 43.47%
2006 $134.02M 39.03%
2005 $96.39M 9.76%
2004 $87.82M 0.00%
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
$651.61M -60.31%
FR
$3.88B 136.40%
DE
$1.32B -19.32%
JP
$3.36B 104.66%
US
$4.84B 194.62%
GB